IRIS
CASABIANCA, ANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.132
EU - Europa 5.862
AS - Asia 3.484
SA - Sud America 344
AF - Africa 66
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 11
Totale 19.920
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.033
GB - Regno Unito 2.249
CN - Cina 1.739
SG - Singapore 959
UA - Ucraina 767
IT - Italia 735
RU - Federazione Russa 472
SE - Svezia 415
FI - Finlandia 333
TR - Turchia 301
DE - Germania 291
BR - Brasile 265
FR - Francia 251
IE - Irlanda 179
VN - Vietnam 165
JP - Giappone 94
CA - Canada 64
IN - India 57
PL - Polonia 39
BE - Belgio 32
MA - Marocco 27
AR - Argentina 26
MX - Messico 22
NL - Olanda 20
ZA - Sudafrica 20
HK - Hong Kong 19
KR - Corea 19
AU - Australia 18
ES - Italia 18
BD - Bangladesh 16
IQ - Iraq 16
CL - Cile 14
EC - Ecuador 14
IR - Iran 12
SA - Arabia Saudita 12
UZ - Uzbekistan 12
DK - Danimarca 11
EU - Europa 10
PY - Paraguay 10
LT - Lituania 9
AE - Emirati Arabi Uniti 7
JO - Giordania 7
KZ - Kazakistan 7
MY - Malesia 7
CH - Svizzera 6
ID - Indonesia 6
AT - Austria 5
VE - Venezuela 5
CO - Colombia 4
EG - Egitto 4
MD - Moldavia 4
PA - Panama 4
PH - Filippine 4
PK - Pakistan 4
PT - Portogallo 4
TG - Togo 4
AZ - Azerbaigian 3
BG - Bulgaria 3
GR - Grecia 3
JM - Giamaica 3
LA - Repubblica Popolare Democratica del Laos 3
LV - Lettonia 3
NO - Norvegia 3
NP - Nepal 3
NZ - Nuova Zelanda 3
OM - Oman 3
AM - Armenia 2
CI - Costa d'Avorio 2
DZ - Algeria 2
EE - Estonia 2
ET - Etiopia 2
HR - Croazia 2
IL - Israele 2
KE - Kenya 2
PE - Perù 2
RO - Romania 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BO - Bolivia 1
CG - Congo 1
CM - Camerun 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
GD - Grenada 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
KG - Kirghizistan 1
KH - Cambogia 1
LK - Sri Lanka 1
NG - Nigeria 1
NI - Nicaragua 1
PR - Porto Rico 1
QA - Qatar 1
RS - Serbia 1
SY - Repubblica araba siriana 1
Totale 19.920
Salva come PNG Salva come JPEG
Città #
Southend 2.069
Fairfield 1.140
Woodbridge 981
Ashburn 932
Ann Arbor 891
Houston 881
Jacksonville 615
Chandler 486
Seattle 461
Cambridge 440
Singapore 439
Dallas 415
Wilmington 388
San Jose 343
Nanjing 332
Beijing 250
Urbino 223
Izmir 222
Boardman 170
Dublin 169
New York 151
Helsinki 150
Nanchang 137
Los Angeles 116
Moscow 108
San Mateo 96
Lauterbourg 95
Princeton 95
Tianjin 84
Shenyang 74
Düsseldorf 68
Ho Chi Minh City 59
Istanbul 58
Changsha 56
Hebei 56
Jiaxing 43
Munich 42
Bremen 41
London 38
Buffalo 36
San Diego 36
Kunming 35
Orem 33
Hanoi 31
São Paulo 30
Council Bluffs 29
Frankfurt am Main 29
Toronto 29
Brussels 28
Jinan 28
Santa Clara 28
Shanghai 28
Velikiy Novgorod 27
San Francisco 26
Hangzhou 25
The Dalles 25
Tokyo 23
Casablanca 21
Chicago 21
Warsaw 21
Guangzhou 19
Hong Kong 19
Turku 19
Seongnam 18
Denver 17
Cagli 16
Milan 16
Zhengzhou 16
Johannesburg 15
Stockholm 15
Lanzhou 14
Montreal 14
Rome 14
Chennai 13
Napoli 13
Amsterdam 12
Boston 12
Brooklyn 12
Des Moines 12
Leawood 12
Manchester 12
Mülheim 12
Taizhou 12
Changchun 11
Kraków 11
Mumbai 11
Ningbo 11
Rio de Janeiro 11
Atlanta 10
Auburn Hills 10
Fano 10
Poplar 10
Tashkent 10
Augusta 9
Falls Church 9
Venice 9
Xi'an 9
Orange 8
Redwood City 8
Amman 7
Totale 14.501
Salva come PNG Salva come JPEG
Nome #
Switching to elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate single-tablet regimen (Stribild†): effects on T-cell compartment and HIV reservoirs 515
Glutathione Depletion Is Linked with Th2 Polarization in Mice with a Retrovirus-Induced Immunodeficiency Syndrome, Murine AIDS: Role of Proglutathione Molecules as Immunotherapeutics 430
Effect of starvation on survival and virulence expression of Aeromonas hydrophila from different sources 358
Antiviral and Immunomodulatory Properties of New Pro-Glutathione (GSH) Molecules. 305
A Real Time PCR Platform for the Simultaneous Quantification of Total and Extrachromosomal HIV DNA Forms in Blood of HIV-1 Infected Patients 293
A recombinant human 'mini'-hexokinase is catalytically active and regulated by hexose 6-phosphates 285
A new one-step RT-PCR method for virus quantitation in murine AIDS. 279
Inhibition of murine AIDS by pro-glutathione (GSH) molecules 276
2',3'-Dideoxycytidine induced drug resistance in human cells 275
2',3'-Dideoxycytidine metabolism in a new drug-resistant cell line 270
2\',3\'-Dideoxycytidine cytotoxicity in human macrophages. 266
Pharmacokinetic and antiretroviral activity in mice of oral [P(1),P(2)-bis[2-(adenin-9-yl)ethoxymethyl]phosphonate], a prodrug of 9-(2-phosphonylmethoxyethyl)adenine 265
Erythrocytes as carriers of antisense PNA addressed against HIV-1 gag-pol transframe domain 263
Effect of macrophage depletion on viral DNA rebound following antiretroviral therapy in a murine model of AIDS (MAIDS) 262
Molecules Altering the Intracellular Thiol Content Modulate NF-kB and STAT-1/IRF-1 Signalling Pathways and IL-12 p40 and IL-27 p28 Production in Murine Macrophages 261
Development of a real time PCR assay using SYBR Green I for provirus load quantification in a murine model of AIDS 260
New Approach using the real-time PCR method for estimation of the toxic marine dinoflagellate Ostreopsis cf. ovata in marine environment 254
HIV-1 Tat immunization restores immune homeostasis and attacks the HAART-resistant blood HIV DNA: results of a randomized phase II exploratory clinical trial 252
2',3'-Dideoxycytidine induced drug-resistance in human cells 251
Fast and sensitive quantitative detection of HIV DNA in whole blood leucocytes by SYBR Green I real-time PCR assay 246
Control of the HIV-1 DNA Reservoir Is Associated In Vivo and In Vitro with NKp46/NKp30 (CD335 CD337) Inducibility and Interferon Gamma Production by Transcriptionally Unique NK Cells 242
Fast and sensitive quantitative detection of HIV DNA in whole blood leucocytes by SYBR green I real-time PCR assay. 240
Development of a real-time PCR assay using SYBR Green I for provirus load quantification in a murine model of AIDS 239
Pharmaceutical composition or composition package containing a pyrimidine nucleoside analog and a purine nucleoside analog 238
Macrophage protection by addition of glutathione (GSH)-loaded erythrocytes to AZT and DDI in a murine AIDS model. 230
Inhibition of murine AIDS by combination of AZT and dideoxycytidine 5'-triphosphate 229
Targeting antiviral nucleotide analogues to macrophages 227
Antiretroviral effect of combined zidovudine and reduced glutathione therapy in murine AIDS. 225
Inhibition of murine AIDS by a heterodinucleotide of azidothymidine and 9-(R)-2-(phosphonomethoxypropyl)adenine 224
Comparative analysis of T-cell turnover and homeostatic parameters in HIV-infected patients with discordant immune-virological responses to HAART 222
Red blood cells as advanced drug delivery systems for antiviral nucleoside analogues 219
Protein degradation and apoptotic death in lymphocytes during fiv infection: activation of the ubiquitin-proteasome proteolytic system , (1999) 381-390 216
Repeated cycles of alternate administration of fludarabine and zidovudine plus didanosine inhibits murine AIDS and reduces proviral DNA content in lymph nodes to undetectable levels 214
HIV-infected long-term nonprogressors display a unique correlative pattern between the interleukin-7/interleukin-7 receptor circuit and T-cell homeostasis 213
Inhibition of murine AIDS by reduced glutathione. 212
Human hexokinase type I microheterogeneity is due to different amino-terminal sequences 209
A comparative analysis of unintegrated HIV-1 DNA measurement as a potential biomarker of the cellular reservoir in the blood of patients controlling and non-controlling viral replication 209
Mitochondria as cellular hub in neonatal hypoxic-ischemic encephalopathy: identification of melatonin-responsive biomarkers predicting brain damage severity 205
Quantification of the Toxic Dinoflagellate Ostreopsis spp. by qPCR Assay in Marine Aerosol 205
Targeting nucleotide dimers containing antiviral nucleosides 204
Monitoring toxic Ostreopsis cf. ovata in recreational waters using a qPCR assay. 204
New treatment protocol including lympholytic and antiretroviral drugs to inhibit murine AIDS 203
HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4(+) T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trial 203
Genetic diversity of the genus Ostreopsis Schmidt:phylogeographical considerations and molecularmethodology applications for field detectionin the Mediterranean Sea 201
Efficient inhibition by Raltegravir of HIV-1 Infection in Human Primary Macrophages and in CD4+T Lymphocytes and of the cellular Apoptosis HIV-1 correlated 199
Increased Bone Marrow Interleukin-7 (IL-7)/IL-7R Levels but Reduced IL-7 Responsiveness in HIV-Positive Patients Lacking CD4+ Gain on Antiviral Therapy 197
Different kinetics of viral replication and DNA integration in the main HIV-1 cellular reservoirs in the presence and absence of integrase inhibitors 197
Continued Decay of HIV Proviral DNA Upon Vaccination With HIV-1 Tat of Subjects on Long-Term ART: An 8-Year Follow-Up Study 196
Immunophenotype and Function of CD38-Expressing CD4+ and CD8+ T Cells in HIVInfected Patients Undergoing Suppressive Combination Antiretroviral Therapy 193
Macrophage protection by nucleoside and nucleotide analogue administration 192
Inhibition of murine AIDS by combination of AZT and DDCTP-loaded erythrocytes 186
Up-regulation of the ubiquitin-conjugating and proteolytic systems in murine acquired immunodeficiency syndrome 184
Inhibition of Murine AIDS by a New Azidothymidine Homodinucleotide. 182
Effect of macrophage depletion on viral DNA rebound following antiretroviral therapy in a murine model of AIDS 182
Competitive PCR for quntification of BM5d proviral DNA in mice with AIDS. 182
Human hexokinase type I microheterogeneity is due to different amino-terminal 181
Molecular studies in Duchenne and Becker muscular dystrophies 180
Synthesis and targeted delivery of an azidothymidine homodinucleotide conferring protection to macrophages against retroviral infection 180
The soluble but not mitochondrially bound hexokinase is a substrate for the ATP- and ubiquitin-dependent proteolytic system 178
Inhibition of murine AIDS by a new azidothymidine homodinucleotide 177
GSH and analogs in antiviral therapy 177
T-Cell Dynamics and Homeostatic Pathways in HAART-Treated HIV-Infected Patients. 177
Efficacy and toxicity of long-term administration of 2',3'-dideoxycytidine in the LP-BM5 murine-induced immunodeficiency model 175
Inhibition of HIV-1 and LP-BM5 replication in macrophages by dideoxycytidine and dideoxycytidine 5'-triphosphate 174
Drug-loaded red blood cell-mediated clearance of HIV-1 macrophage reservoir by selective inhibition of STAT1 expression. 174
Comparing Heterologous and Homologous {COVID}-19 Vaccination: A Longitudinal Study of Antibody Decay 174
A p12 gag gene homologue is present in the mouse genome. 173
Metabolism, mitochondrial uptake and toxicity of 2’,3’-dideoxycytidine 172
HIV-infected long-term nonprogressors display a unique correlative pattern between the interleukin-7/interleukin-7 receptor circuit and T-cell homeostasis. 172
Protein degradation and apoptotic death in lymphocytes during FIV infection: activation of the ubiquitin-proteasome proteolytic system 171
Inhibition of murine retrovirus induced immunodeficiency by nucleoside analogues and combination therapy. 171
Liposomes as carriers of the antiretroviral agent dideoxycytidine-5'-triphosphate. 170
Erythrocyte-based targeted release to macrophages of an azidothymidine homodinucleotide prevents retroviral infection 168
Macrophage protection by nucleoside and nucleotide analogue administration 166
Erythrocytes as carriers of reduced glutathione (GSH) in the treatment of retroviral infections 166
BIOTECNOLOGIE: APPLICAZIONI NEL SETTORE MEDICO E FARMACEUTICO 164
Inhibition of murine AIDS by alternate administration of azidothimidine and fludarabine monofosfate. 163
Evaluation of Two-Month Antibody Levels after Heterologous ChAdOx1-S/BNT162b2 Vaccination Compared to Homologous ChAdOx1-S or BNT162b2 Vaccination 162
Targeting antiviral nucleotide analogues to macrophages 161
Molecular basis of the 2',3'-dideoxycytidine induced drug-resistance in human cells 160
Macrophage depletion by Clodronate-loaded erythrocytes 157
Red blood cells as carriers of drugs against retroviruses 157
Hexokinase is not ubiquitaned when mitochondrial-bound 152
Role of macrophage protection in the development of murine AIDS. 149
Reduction of Immune Activation and Partial Recovery of Staphylococcal Enterotoxin B-Induced Cytokine Production After Switching to an Integrase Strand Transfer Inhibitor-Containing Regimen: Results from an Observational Cohort Study 149
New drug combinations for the treatment of murine AIDS and macrophage protection. 148
Studio delle dinamiche di crescita di Ostreopsis cf. ovata con nuove metodologie molecolari di qrt-PCR 142
Inhibition of murine retrovirus induced immunodeficiency by nucleoside analogues and combination therapy. 141
Role of macrophage protection in the development of murine AIDS 137
Melatonin Reduces Mito-Inflammation in Ischaemic Hippocampal HT22 Cells and Modulates the cGAS–STING Cytosolic DNA Sensing Pathway and FGF21 Release 131
The inhibitory effect of ddC on HIV replication diminishes in cells that are chronically exposed to the drug 128
Red blood cells as carriers of antiviral agents 111
Persistence of Unintegrated HIV DNA Associates With Ongoing NK Cell Activation and CD34+DNAM-1brightCXCR4+ Precursor Turnover in Vertically Infected Patients Despite Successful Antiretroviral Treatment 111
Analysis of humoral and cellular immune activation up to 21 months after heterologous and homologous COVID-19 vaccination 110
Red blood cells as carriers af antiviral agents 106
Rapid monitoring of SARS-CoV-2 variants of concern through high-resolution melt analysis 105
External quality assessment of HIV-1 DNA quantification assays used in the clinical setting in Italy 104
Primary HIV infection features colonic damage and neutrophil inflammation yet containment of microbial translocation 93
SARS-CoV-2 RNA Detection on Environmental Surfaces in a University Setting of Central Italy 92
Prevalence of SARS-CoV-2 infection in the workplace: results of a year of investigation in the Marche Nord companies 83
Totale 19.981
Salva come PNG Salva come JPEG
Categoria #
all - tutte 65.514
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.514
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021479 0 0 0 0 0 0 0 0 0 153 247 79
2021/20221.149 85 97 111 127 31 59 45 60 108 87 66 273
2022/20231.551 191 66 18 189 163 332 7 103 292 62 75 53
2023/2024493 42 35 38 42 34 158 14 34 2 45 3 46
2024/20251.659 89 55 334 106 59 110 215 86 186 117 191 111
2025/20263.835 377 384 613 713 369 275 422 123 341 218 0 0
Totale 20.155